Skip to content
healthcare services hero image
healthcare services hero image

Healthcare Services

Allen & Overy can provide legal services creating a solid foundation for your healthcare infrastructure projects.

Development and provision of specialised healthcare infrastructure is one of the key themes in modern times and requires specialist advice. The unique issues raised by the public service nature of hospitals, nursing homes, rehabilitation centres, clinics, academic and commercial R&D facilities always challenge investors, sponsors and lenders. As a global firm, we can successfully guide you through all stages of the lifecycle of healthcare infrastructure projects. In the healthcare infrastructure sector, we regularly advise on lettings and leasings, development, planning and construction, environmental issues and implications, private/public partnerships, including public procurement, transitional employment issues, commercial agreements with stakeholders, outsourcing, data protection and privacy, strategic licensing and collaboration agreements, global joint ventures, M&A and restructuring.

News & insights

A person holding a test tube containing cannabis leaves

Publications: 29 NOVEMBER 2019

Flying high

As more countries liberalise their cannabis policies, there has been a rapid increase in the number of registered IP rights as competitors seek to establish their places in the market.

Read more

Publications: 04 OCTOBER 2019

Outstanding performance by A&O in global M&A league tables

A&O has marked the end of Q3 2019 with an outstanding performance in the M&A league tables; the result of advising on a number of complex, high-value transactions in a wide range of sectors and markets, around our global network in 2019.

Read more

Publications: 02 SEPTEMBER 2019

China: amendment to Drug Administration Law

On August 26, 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on December 1.

Read more

Publications: 28 AUGUST 2019

NICE consults on Draft Guideline on prescribing medicinal cannabis

On 8 August 2019, the National Institute for Health and Care Excellence (NICE)1 published a draft guideline on prescribing cannabis-based medicinal products (the Draft Guideline) for consultation.2

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2019

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.

Related expertise